# DESCRIPTION

## BACKGROUND OF THE INVENTION

The maintenance of genomic integrity is a fundamental biological imperative that has been evolutionarily conserved across eukaryotic organisms, from yeast to humans. Cells are continuously exposed to endogenous and exogenous sources of DNA damage, including reactive oxygen species, ionizing radiation, ultraviolet light, and replication errors, all of which threaten the fidelity of the genetic code. To counteract these threats, organisms have developed a sophisticated network of DNA repair pathways that detect, signal, and rectify various forms of DNA lesions. Among the most cytotoxic forms of DNA damage are double-strand breaks (DSBs), which, if left unrepaired or misrepaired, can lead to chromosomal translocations, deletions, amplifications, and ultimately cellular dysfunction, senescence, or malignant transformation. Two primary pathways have been identified as responsible for the repair of DSBs: non-homologous end joining (NHEJ) and homology-directed repair (HDR). These pathways operate with distinct mechanisms, efficiencies, and outcomes, and their relative dominance varies depending on cell type, cell cycle phase, and the molecular context of the break.

NHEJ is the predominant DSB repair mechanism in mammalian somatic cells, particularly during the G1 phase of the cell cycle. It functions by directly ligating the broken DNA ends without requiring a homologous template. The core machinery of classical NHEJ includes the Ku70-Ku80 heterodimer, which binds rapidly to exposed DNA ends and serves as a scaffold for the recruitment of other essential factors, including DNA-dependent protein kinase catalytic subunit (DNA-PKcs), Artemis, XLF, XRCC4, and DNA ligase IV (LIG4). This pathway is inherently error-prone because it does not rely on sequence homology to guide repair; instead, it often results in small insertions or deletions (indels) at the break site due to nucleolytic processing and imperfect ligation. While this imprecision is tolerable in non-coding regions or for gene disruption applications, it renders NHEJ unsuitable for applications requiring precise sequence modification, such as the correction of disease-causing point mutations or the targeted insertion of transgenes.

In contrast, HDR is a high-fidelity repair pathway that utilizes an undamaged homologous DNA sequence as a template to restore the broken locus with nucleotide precision. This pathway is active primarily during the S and G2 phases of the cell cycle, when sister chromatids are available as templates. Key components of HDR include the MRN complex (MRE11-RAD50-NBS1), which initiates end resection to generate 3′ single-stranded DNA overhangs; the BRCA1 and BRCA2 tumor suppressor proteins, which facilitate the loading of RAD51 onto single-stranded DNA; and RAD51, which forms a nucleoprotein filament that searches for and invades homologous sequences. The resulting displacement loop (D-loop) serves as a primer for DNA synthesis, after which the newly synthesized strand is resolved and ligated to complete the repair. Because HDR can incorporate exogenous donor DNA templates, it is the only pathway capable of enabling precise genome editing, such as knock-ins, point mutation corrections, or tag insertions. However, in mammalian cells, HDR is significantly less efficient than NHEJ, typically occurring at frequencies 5- to 20-fold lower, depending on the cell type and experimental conditions. This inefficiency has long been a major bottleneck in the application of CRISPR-Cas9 and other programmable nucleases for therapeutic genome editing, where precision is paramount.

The advent of CRISPR-Cas9 technology revolutionized the field of genome editing by providing a simple, programmable, and highly specific means of inducing targeted DSBs. When combined with a donor DNA template, Cas9-mediated cleavage enables HDR-driven precise modifications. However, the inherent bias of mammalian cells toward NHEJ severely limits the utility of this approach. Numerous strategies have been pursued to overcome this limitation, including chemical inhibition of NHEJ components, synchronization of cells into S/G2 phases, fusion of Cas9 with cell-cycle-regulated domains, and overexpression of HDR-promoting factors. Small molecule inhibitors such as SCR7, which targets LIG4, or RS-1, which activates RAD51, have shown modest improvements in HDR efficiency, often in the range of two- to three-fold. However, these compounds frequently exhibit off-target effects, cytotoxicity, poor bioavailability, and inconsistent performance across cell types. For instance, SCR7 has been reported to induce apoptosis in pluripotent stem cells and to have negligible effects on HDR at endogenous loci in certain human cell lines. Similarly, pharmacological agents such as L755507 and Brefeldin A, identified through high-throughput screening, show variable efficacy and are not suitable for in vivo applications due to their instability and potential systemic toxicity.

Cell cycle manipulation strategies, such as the use of aphidicolin or nocodazole to arrest cells in S or G2 phases, or the fusion of Cas9 with the Geminin degron domain to restrict its activity to S/G2, have also been explored. While these methods can enhance HDR by 1.5- to 2-fold, they are impractical for in vivo use, as they disrupt the delicate temporal and spatial regulation of the cell cycle in tissues and organs. Moreover, prolonged cell cycle arrest induces stress responses, alters gene expression profiles, and compromises cell viability. Alternative genetic approaches, such as the overexpression of RAD51, BRCA1, or CtIP, have demonstrated some success but require constitutive transgene expression, which can lead to genomic instability, oncogenic transformation, or unintended perturbations in DNA damage signaling. Furthermore, many of these strategies rely on the simultaneous delivery of multiple plasmids or viral vectors, increasing complexity, cost, and immunogenic risk.

There remains a critical unmet need for a robust, scalable, and safe method to enhance HDR efficiency in mammalian cells without relying on exogenous chemicals, cell cycle arrest, or constitutive overexpression of DNA repair factors. Such a method must be genetically encoded, programmable, reversible, and compatible with diverse delivery platforms—including plasmids, lentiviruses, and adeno-associated viruses—to enable both in vitro and in vivo applications. It must also be compatible with the CRISPR-Cas9 system, allowing for the simultaneous execution of genome editing and modulation of the DNA repair landscape using a single nuclease. The present invention fulfills this need by introducing a novel and highly versatile system that exploits the dual functionality of catalytically inactive guide RNAs (dgRNAs) in conjunction with an active Cas9 nuclease to transcriptionally reprogram the balance between NHEJ and HDR pathways. By simultaneously activating key HDR-promoting genes and repressing critical NHEJ components using CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) modules, this system achieves a dramatic and reproducible enhancement of precise genome editing without compromising cell viability or requiring pharmacological intervention. This approach represents a paradigm shift in genome editing strategy, moving from brute-force chemical or cell cycle manipulation to intelligent, gene-regulatory fine-tuning of the endogenous DNA repair machinery.

## SUMMARY OF THE INVENTION

The present invention provides a novel and highly effective method for enhancing homology-directed repair (HDR) efficiency in mammalian cells through the transcriptional reprogramming of DNA damage repair pathways using a single catalytically active Cas9 nuclease in combination with engineered catalytically inactive guide RNAs (dgRNAs). Unlike prior approaches that rely on chemical inhibitors, cell cycle synchronization, or constitutive overexpression of repair factors, this invention leverages the ability of dgRNAs to recruit transcriptional activators or repressors to specific genomic loci without inducing DNA cleavage, thereby enabling precise, reversible, and programmable modulation of endogenous gene expression. The system is designed to simultaneously activate genes that promote HDR while repressing genes that drive the competing non-homologous end joining (NHEJ) pathway, thereby shifting the cellular repair balance in favor of precise genome editing.

The invention comprises a set of engineered nucleic acid constructs that encode for two distinct dgRNA scaffolds, each fused to a modular effector domain capable of either activating or repressing transcription. The first construct, referred to herein as the CRISPR activation (CRISPRa) module, contains a dgRNA scaffold engineered to include MS2 RNA aptamers, which recruit a fusion protein consisting of the MS2 coat protein (MCP) fused to the transcriptional activators P65 and HSF1 (MCP-P65-HSF1, or MPH). This construct is designed to target the promoter regions of key HDR-promoting genes, such as CDK1 and CtIP, thereby enhancing their transcriptional output. The second construct, referred to as the CRISPR interference (CRISPRi) module, contains a dgRNA scaffold engineered to include Com RNA aptamers, which recruit a fusion protein consisting of the Com protein fused to the Krüppel-associated box (KRAB) repressor domain (Com-KRAB, or CK). This construct is designed to target the promoter regions of key NHEJ-promoting genes, such as KU70, KU80, and LIG4, thereby suppressing their expression.

Crucially, both the CRISPRa and CRISPRi constructs are co-expressed with a catalytically active Cas9 nuclease and a standard single guide RNA (sgRNA) that directs Cas9 to induce a double-strand break at the target genomic locus intended for editing. This configuration allows for the simultaneous execution of two distinct functions: the sgRNA directs Cas9 to create a site-specific DSB, while the dgRNAs direct transcriptional modulation of the DNA repair machinery. Because the dgRNAs are catalytically inactive—typically 14 to 15 nucleotides in length—they retain the ability to bind Cas9 and localize to the intended genomic target site but are incapable of inducing DNA cleavage. This enables the system to perform genome editing and transcriptional regulation in the same cell, using the same Cas9 protein, without requiring additional nucleases or complex multi-component delivery systems.

The invention further includes inducible expression systems that allow for temporal control over the activation and repression of HDR and NHEJ genes. In one embodiment, the CRISPRa and CRISPRi effectors are placed under the control of a tetracycline-responsive promoter (TRE3G), which is activated in the presence of doxycycline. This allows researchers to precisely time the modulation of DNA repair gene expression relative to the delivery of the Cas9-sgRNA complex and the HDR donor template, minimizing potential off-target effects and enabling reversible control. In another embodiment, the entire system is packaged into lentiviral vectors for stable integration and long-term expression, facilitating the generation of cell lines with constitutive or inducible HDR enhancement capabilities.

The invention has been validated across multiple mammalian cell lines, including HEK293, HEK293T, HeLa, and HEK293FT cells, and has been shown to enhance HDR efficiency by up to eight-fold at both exogenous reporter loci and endogenous genomic sites, such as the AAVS1 and ACTB loci. The enhancement is achieved without inducing significant cytotoxicity, altering cell cycle distribution, or compromising cell viability, as confirmed by flow cytometry, cell cycle analysis, and cell viability assays. The system is highly specific, as evidenced by the absence of off-target transcriptional changes and the precise integration of donor sequences into the target locus, as confirmed by Sanger sequencing and deep sequencing of HDR-positive clones.

The invention provides a powerful, scalable, and broadly applicable platform for precise genome editing that overcomes the longstanding limitations of low HDR efficiency in mammalian cells. It enables the efficient insertion of large DNA cassettes, correction of disease-causing mutations, and tagging of endogenous genes with fluorescent or affinity tags—all with unprecedented precision and efficiency. Moreover, because the system is entirely genetically encoded and compatible with viral delivery systems, it is uniquely suited for therapeutic applications in vivo, including ex vivo editing of hematopoietic stem cells, in vivo correction of liver or retinal disorders, and the generation of genetically modified animal models. The invention represents a transformative advance in the field of genome engineering, providing a safe, programmable, and highly effective means of tipping the balance of DNA repair toward high-fidelity homology-directed repair.

## DETAILED DESCRIPTION

### Definitions

For the purposes of this patent application, the following terms shall have the meanings ascribed below, unless the context clearly indicates otherwise. The term “catalytically inactive guide RNA” or “dgRNA” refers to a synthetic RNA molecule that is capable of forming a complex with a Cas9 protein and directing it to a specific genomic locus via Watson-Crick base pairing, but which is structurally altered such that it does not induce a double-strand break at the target site. In one embodiment, the dgRNA is 14 to 15 nucleotides in length, which is insufficient to trigger the conformational change in Cas9 required for nuclease activation. In another embodiment, the dgRNA contains mismatches or bulges in the seed region that prevent cleavage while preserving binding affinity. The dgRNA retains the ability to recruit effector domains fused to Cas9 or to auxiliary RNA-binding proteins, thereby enabling transcriptional modulation without DNA cleavage.

The term “CRISPR activation” or “CRISPRa” refers to a method of upregulating gene expression by recruiting transcriptional activators to the promoter or enhancer regions of a target gene using a catalytically inactive Cas9 or a dgRNA scaffold fused to an activator domain. In the context of this invention, CRISPRa is achieved by fusing the MS2 coat protein to the transcriptional activators P65 and HSF1, and by incorporating MS2 RNA aptamers into the dgRNA scaffold, such that the MS2-MPH fusion protein is recruited to the promoter region of the target gene upon dgRNA binding.

The term “CRISPR interference” or “CRISPRi” refers to a method of downregulating gene expression by recruiting transcriptional repressors to the promoter or enhancer regions of a target gene using a catalytically inactive Cas9 or a dgRNA scaffold fused to a repressor domain. In the context of this invention, CRISPRi is achieved by fusing the Com protein to the Krüppel-associated box (KRAB) repressor domain, and by incorporating Com RNA aptamers into the dgRNA scaffold, such that the Com-CK fusion protein is recruited to the promoter region of the target gene upon dgRNA binding.

The term “homology-directed repair” or “HDR” refers to a high-fidelity DNA repair pathway that utilizes a homologous DNA template to restore the sequence of a double-strand break with nucleotide precision. HDR is active during the S and G2 phases of the cell cycle and requires the presence of a sister chromatid or an exogenous donor DNA molecule containing homologous flanking sequences. HDR enables precise genome editing, including gene knock-ins, point mutation corrections, and epitope tagging.

The term “non-homologous end joining” or “NHEJ” refers to a dominant DNA repair pathway in mammalian cells that ligates broken DNA ends without the use of a homologous template. NHEJ is active throughout the cell cycle but predominates in G1 phase. It is inherently error-prone and often results in small insertions or deletions (indels) at the break site, leading to frameshift mutations or loss of gene function.

The term “classical NHEJ” or “C-NHEJ” refers to the canonical pathway of NHEJ that requires the Ku70-Ku80 heterodimer, DNA-PKcs, Artemis, XRCC4, XLF, and LIG4. C-NHEJ is the primary pathway for DSB repair in mammalian cells and is responsible for the majority of indel mutations observed after CRISPR-Cas9 cleavage.

The term “micro-homology-mediated end joining” or “MMEJ” refers to an alternative end-joining pathway that utilizes 5 to 25 base pairs of microhomologous sequences flanking the break site to align and ligate the ends. MMEJ is distinct from C-NHEJ and HDR, and it results in deletions flanked by microhomologous sequences. MMEJ is often considered a subset of alternative end joining (Alt-EJ) and is more mutagenic than C-NHEJ.

The term “donor template” or “HDR donor” refers to a nucleic acid molecule provided exogenously to a cell to serve as a template for HDR-mediated repair of a Cas9-induced double-strand break. The donor template typically contains homology arms flanking a desired sequence insertion, such as a fluorescent protein, epitope tag, or corrected coding sequence. The homology arms are typically 400 to 1000 base pairs in length and are homologous to the genomic sequences immediately adjacent to the target site.

The term “traffic light reporter” or “TLR” refers to a synthetic genetic construct that enables the simultaneous quantification of HDR and NHEJ outcomes in a single cell. The TLR contains a non-functional fluorescent reporter gene (e.g., broken-frame Venus) adjacent to a second fluorescent reporter gene (e.g., frame-shifted mCherry) linked by a self-cleaving peptide (T2A). Repair of the break by HDR restores the functional Venus sequence, while repair by NHEJ can restore the reading frame of mCherry in approximately one-third of events. Thus, Venus-positive/mCherry-negative cells represent HDR events, while Venus-negative/mCherry-positive cells represent NHEJ events.

The term “inducible expression system” refers to a genetic system in which the expression of a transgene is controlled by an external chemical inducer. In one embodiment, the Tet-On system is used, in which the presence of doxycycline induces the binding of the reverse tetracycline-controlled transactivator (rtTA) to the TRE3G promoter, thereby activating transcription of downstream genes encoding CRISPRa or CRISPRi effectors.

The term “lentiviral vector” refers to a modified retroviral vector derived from HIV-1 that is capable of stably integrating into the genome of both dividing and non-dividing cells. Lentiviral vectors are commonly used for gene delivery in mammalian cells and are engineered to be replication-incompetent by deletion of viral genes such as gag, pol, and env, which are provided in trans during packaging.

The term “homology arm” refers to a sequence of DNA that is identical or nearly identical to a genomic region flanking a target site and is used to direct homologous recombination during HDR. The left homology arm is homologous to the sequence upstream of the break site, and the right homology arm is homologous to the sequence downstream of the break site.

The term “transfection” refers to the process of introducing nucleic acids into eukaryotic cells using chemical, physical, or biological methods, including lipofection, electroporation, or microinjection.

The term “transduction” refers to the process of introducing nucleic acids into cells using viral vectors, such as lentivirus or adeno-associated virus.

The term “flow cytometry” refers to a technique for analyzing and sorting individual cells based on their fluorescent or light-scattering properties using a flow cytometer.

The term “Sanger sequencing” refers to a method of DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides during DNA replication, followed by capillary electrophoresis to determine the nucleotide sequence.

The term “qRT-PCR” refers to quantitative reverse transcription polymerase chain reaction, a method used to measure the relative abundance of specific mRNA transcripts in a cell population.

The term “cell viability” refers to the proportion of living cells in a population, typically assessed using metabolic assays such as the Cell Counting Kit-8 (CCK-8), which measures mitochondrial activity.

The term “constitutive expression” refers to the continuous, unregulated expression of a gene under the control of a strong promoter, such as CMV or EF1α.

The term “programmable” refers to the ability to design and implement specific genetic modifications by altering the sequence of guide RNAs to target different genomic loci without changing the underlying effector machinery.

The term “single Cas9 transgene” refers to a genetic construct encoding a single Cas9 protein that is expressed in a cell and used in conjunction with multiple guide RNAs to perform multiple functions, including DNA cleavage, transcriptional activation, and transcriptional repression.

The term “endogenous locus” refers to a genomic site that is naturally present in the genome of an organism, as opposed to an exogenous reporter gene or transgene introduced by transfection or transduction.

The term “gene knock-in” refers to the precise insertion of a foreign DNA sequence into a specific genomic locus via HDR, resulting in the stable integration of the sequence without disruption of endogenous regulatory elements.

The term “epitope tag” refers to a short peptide sequence, such as FLAG, HA, or Myc, that is fused to a protein of interest to facilitate its detection, purification, or localization.

The term “self-cleaving peptide” refers to a short amino acid sequence, such as T2A, P2A, or E2A, that mediates ribosomal skipping during translation, resulting in the production of two separate proteins from a single open reading frame.

The term “polyA signal” refers to a nucleotide sequence, such as SV40 or BGH, that directs the addition of a polyadenylate tail to the 3′ end of an mRNA transcript, thereby enhancing its stability and translation efficiency.

The term “splice acceptor” refers to a consensus sequence, typically located at the 3′ end of an intron, that directs the splicing machinery to join downstream exons to upstream exons, enabling the expression of a downstream open reading frame in frame with an upstream promoter.

The term “AAVS1 locus” refers to a well-characterized safe harbor locus in the human genome, located in the first intron of the PPP1R12C gene on chromosome 19, which permits stable and high-level transgene expression without disrupting endogenous gene function.

The term “ACTB locus” refers to the gene encoding beta-actin, a highly expressed cytoskeletal protein, which is commonly used as a site for targeted transgene insertion due to its open chromatin state and high transcriptional activity.

The term “HEK293 cells” refers to human embryonic kidney cells that have been immortalized and are widely used as a model system for transfection and gene expression studies.

The term “HEK293T cells” refers to a derivative of HEK293 cells that express the SV40 large T antigen, enabling high-level replication of plasmids containing the SV40 origin of replication.

The term “HeLa cells” refers to a human cervical cancer cell line that is widely used in biomedical research due to its robust growth and high transfection efficiency.

The term “hygromycin,” “puromycin,” “blasticidin,” and “G418” refer to antibiotics used for the selection of mammalian cells stably expressing resistance genes such as hygromycin phosphotransferase, puromycin N-acetyltransferase, blasticidin S deaminase, and neomycin phosphotransferase, respectively.

The term “doxycycline” refers to a tetracycline-class antibiotic that acts as an inducer in the Tet-On system by binding to rtTA and enabling its interaction with the TRE3G promoter.

The term “MS2 coat protein” refers to a bacteriophage-derived RNA-binding protein that specifically recognizes and binds to MS2 RNA stem-loop structures.

The term “Com protein” refers to a bacteriophage-derived RNA-binding protein that specifically recognizes and binds to Com RNA stem-loop structures.

The term “P65” refers to the RelA subunit of the NF-κB transcription factor, which functions as a potent transcriptional activator.

The term “HSF1” refers to heat shock factor 1, a transcription factor that activates genes involved in the heat shock response and enhances transcriptional elongation.

The term “KRAB domain” refers to the Krüppel-associated box, a conserved repressor domain found in many zinc finger proteins that recruits heterochromatin-forming complexes to silence gene expression.

The term “TRE3G promoter” refers to a synthetic, highly sensitive tetracycline-responsive promoter variant that exhibits low basal expression and high inducibility in the presence of doxycycline.

The term “rtTA” refers to the reverse tetracycline-controlled transactivator, a chimeric protein composed of the Tet repressor and the VP16 activation domain, which binds to TRE promoters only in the presence of doxycycline.

The term “lentiviral packaging system” refers to a set of plasmids that provide the necessary viral proteins (gag, pol, rev) and envelope (VSV-G) for the production of replication-incompetent lentiviral particles.

The term “adeno-associated virus” or “AAV” refers to a small, non-pathogenic, single-stranded DNA virus that is widely used as a gene delivery vector in clinical gene therapy due to its low immunogenicity and ability to transduce both dividing and non-dividing cells.

The term “ex vivo” refers to procedures performed outside the living organism, typically involving the isolation, manipulation, and reinfusion of cells.

The term “in vivo” refers to procedures performed within a living organism.

The term “therapeutic genome editing” refers to the use of genome editing technologies to correct, disrupt, or replace disease-causing genetic variants in human cells for the purpose of treating or preventing disease.

The term “precise genome editing” refers to the modification of a genomic locus with nucleotide-level accuracy, typically achieved through HDR and verified by sequencing.

The term “off-target effect” refers to unintended genetic modifications at genomic sites other than the intended target, which may arise due to partial complementarity between guide RNAs and non-target sequences.

The term “chromatin accessibility” refers to the degree to which DNA is physically accessible to transcription factors and other regulatory proteins, often determined by the presence of open chromatin marks such as H3K27ac or DNase I hypersensitivity.

The term “transcriptional output” refers to the level of mRNA produced from a gene, typically measured by qRT-PCR or RNA sequencing.

The term “genomic integration” refers to the stable incorporation of exogenous DNA into the host genome, as opposed to transient episomal expression.

The term “multiplexed editing” refers to the simultaneous targeting of multiple genomic loci using multiple guide RNAs.

The term “nucleic acid construct” refers to any engineered DNA or RNA molecule designed for expression in a host cell, including plasmids, viral vectors, and synthetic RNA molecules.

The term “expression cassette” refers to a DNA sequence containing a promoter, coding sequence, and terminator necessary for the expression of a gene in a host cell.

The term “transgene” refers to a gene or genetic construct introduced into an organism from an external source.

The term “stable cell line” refers to a population of cells that have stably integrated an exogenous nucleic acid construct into their genome and express the encoded protein over multiple generations.

The term “transient transfection” refers to the introduction of nucleic acids into cells without stable integration, resulting in short-term expression.

The term “viral transduction” refers to the delivery of nucleic acids into cells using viral vectors.

The term “cell cycle phase” refers to the stage of the cell division cycle, including G1, S, G2, and M phases.

The term “DNA end resection” refers to the 5′ to 3′ nucleolytic degradation of DNA ends at a double-strand break to generate single-stranded overhangs, a critical step in initiating HDR.

The term “RAD51 filament” refers to the nucleoprotein structure formed by RAD51 bound to single-stranded DNA, which is essential for homology search and strand invasion during HDR.

The term “MRN complex” refers to the MRE11-RAD50-NBS1 protein complex that initiates DNA end resection and activates the ATM kinase in response to double-strand breaks.

The term “BRCA1/2” refers to the breast cancer susceptibility proteins that play critical roles in the regulation of RAD51 loading and homologous recombination.

The term “LIG4” refers to DNA ligase IV, the enzyme responsible for the final ligation step in classical NHEJ.

The term “Ku70/Ku80” refers to the heterodimeric complex that binds to DNA ends and initiates classical NHEJ.

The term “CtIP” refers to the C-terminal binding protein interacting protein, a nuclease that promotes DNA end resection and is essential for HDR initiation.

The term “CDK1” refers to cyclin-dependent kinase 1, a kinase that phosphorylates CtIP and other resection factors to promote HDR.

The term “T2A peptide” refers to a self-cleaving peptide derived from the porcine teschovirus-1 2A sequence that enables the co-expression of two proteins from a single open reading frame.

The term “EGFP” refers to enhanced green fluorescent protein, a variant of green fluorescent protein with improved brightness and stability.

The term “mCherry” refers to a red fluorescent protein derived from Discosoma sp. that is commonly used as a reporter for gene expression or cell labeling.

The term “Venus” refers to a yellow fluorescent protein variant derived from GFP with improved maturation kinetics and brightness.

The term “fluorescent reporter” refers to a protein that emits detectable light upon excitation, used to visualize gene expression or cellular processes.

The term “Sanger sequencing” refers to the dideoxy chain termination method of DNA sequencing.

The term “deep sequencing” refers to high-throughput next-generation sequencing used to analyze the frequency and spectrum of genomic edits.

The term “clonal isolation” refers to the process of deriving a population of genetically identical cells from a single progenitor cell.

The term “phenotypic screening” refers to the identification of cells based on observable characteristics, such as fluorescence, morphology, or drug resistance.

The term “genotypic analysis” refers to the determination of the exact DNA sequence at a genomic locus.

The term “control vector” refers to a nucleic acid construct lacking the active components of the invention, used as a baseline for comparison.

The term “unpaired t-test” refers to a statistical test used to compare the means of two independent groups.

The term “paired t-test” refers to a statistical test used to compare the means of two related groups, such as before and after treatment.

The term “standard error of the mean” or “SEM” refers to a measure of the variability of the sample mean.

The term “p-value” refers to the probability that the observed result occurred by chance, with values less than 0.05 generally considered statistically significant.

The term “biological replicate” refers to an independent experiment performed using separate cell cultures or animals.

The term “technical replicate” refers to repeated measurements within the same experiment.

The term “transcriptional repression” refers to the reduction in the rate of gene transcription, typically mediated by histone deacetylation, DNA methylation, or chromatin compaction.

The term “transcriptional activation” refers to the increase in the rate of gene transcription, typically mediated by histone acetylation, recruitment of RNA polymerase, or chromatin remodeling.

The term “nucleic acid hybridization” refers to the base-pairing interaction between complementary nucleic acid strands.

The term “RNA aptamer” refers to a structured RNA molecule that binds with high affinity and specificity to a target protein.

The term “fusion protein” refers to a protein created by joining two or more genes or coding sequences that originally coded for separate proteins.

The term “plasmid” refers to a small, circular, double-stranded DNA molecule capable of autonomous replication in bacterial or eukaryotic cells.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material into a host cell.

The term “transduction efficiency” refers to the percentage of cells that have successfully taken up and expressed a viral vector.

The term “delivery vehicle” refers to a method or system used to introduce nucleic acids into cells, including plasmids, liposomes, nanoparticles, or viral vectors.

The term “gene therapy” refers to the therapeutic delivery of nucleic acids into a patient’s cells to treat or prevent disease.

The term “safe harbor locus” refers to a genomic site that permits stable transgene expression without disrupting endogenous gene function or causing insertional mutagenesis.

The term “episomal” refers to a nucleic acid molecule that exists outside the chromosome and does not integrate into the genome.

The term “chromosomal integration” refers to the stable incorporation of exogenous DNA into a host chromosome.

The term “genomic stability” refers to the maintenance of the integrity and structure of the genome over time.

The term “cellular fitness” refers to the ability of a cell to survive, proliferate, and function normally under given conditions.

The term “off-target transcriptional modulation” refers to unintended changes in gene expression at loci other than the intended target due to partial complementarity of guide RNAs.

The term “specificity” refers to the ability of a system to act only on the intended target and not on related or similar sequences.

The term “efficacy” refers to the ability of a system to produce the desired biological effect.

The term “scalability” refers to the ability to apply the system to multiple targets, cell types, or organisms with minimal modification.

The term “modularity” refers to the ability to interchange components, such as effector domains or guide RNA sequences, without altering the core system.

The term “genetic tool” refers to any engineered nucleic acid or protein used to manipulate gene expression or genome structure.

The term “nuclease” refers to an enzyme that cleaves nucleic acids.

The term “endonuclease” refers to a nuclease that cleaves nucleic acids internally.

The term “exonuclease” refers to a nuclease that cleaves nucleic acids from the ends.

The term “DNA repair machinery” refers to the ensemble of proteins and complexes involved in detecting and repairing DNA damage.

The term “DNA damage response” refers to the cellular signaling network activated in response to DNA damage, including sensors, transducers, and effectors.

The term “chromatin state” refers to the physical and chemical modifications of chromatin that influence gene expression, including histone modifications, DNA methylation, and nucleosome positioning.

The term “epigenetic regulation” refers to heritable changes in gene expression that do not involve changes to the underlying DNA sequence.

The term “transcriptional elongation” refers to the process by which RNA polymerase synthesizes RNA from a DNA template after initiation.

The term “promoter” refers to a DNA sequence upstream of a gene that directs the binding of RNA polymerase and transcription factors to initiate transcription.

The term “enhancer” refers to a distal DNA sequence that increases the transcription of a gene through looping interactions with the promoter.

The term “silencer” refers to a DNA sequence that represses transcription.

The term “insulator” refers to a DNA sequence that blocks the influence of enhancers or silencers on neighboring genes.

The term “polymerase chain reaction” or “PCR” refers to a method of amplifying a specific DNA sequence using primers and a DNA polymerase.

The term “agarose gel electrophoresis” refers to a method of separating DNA fragments by size using an electric field applied across a gel matrix.

The term “DNA purification” refers to the isolation of DNA from cellular components using chemical or physical methods.

The term “nucleic acid extraction” refers to the process of isolating DNA or RNA from cells or tissues.

The term “cell lysis” refers to the disruption of the cell membrane to release intracellular contents.

The term “centrifugation” refers to the process of separating components of a mixture by spinning at high speed.

The term “resuspension” refers to the process of dissolving a pellet in a liquid medium.

The term “incubation” refers to the process of allowing a reaction to proceed under controlled conditions.

The term “temperature” refers to the degree of heat or cold of a substance, typically measured in degrees Celsius.

The term “CO2 incubator” refers to an environmental chamber that maintains a controlled atmosphere of carbon dioxide, humidity, and temperature for cell culture.

The term “cell density” refers to the number of cells per unit volume.

The term “confluence” refers to the percentage of a culture dish or well that is covered by adherent cells.

The term “passaging” refers to the process of transferring cells to a new culture vessel to maintain exponential growth.

The term “cryopreservation” refers to the long-term storage of cells at ultra-low temperatures.

The term “serum-free medium” refers to a cell culture medium that does not contain animal serum.

The term “antibiotic selection” refers to the use of antibiotics to kill cells that have not taken up a resistance gene.

The term “fluorescence-activated cell sorting” or “FACS” refers to a technique for sorting cells based on their fluorescence properties.

The term “gate” refers to a defined region in a flow cytometry plot used to select a subset of cells for analysis or sorting.

The term “population” refers to a group of cells sharing a common characteristic.

The term “subpopulation” refers to a subset of a larger population.

The term “baseline” refers to the control condition against which experimental results are compared.

The term “fold enhancement” refers to the ratio of the experimental value to the control value.

The term “statistical significance” refers to a result that is unlikely to have occurred by chance, as determined by a statistical test.

The term “reproducibility” refers to the ability to obtain consistent results across independent experiments.

The term “robustness” refers to the ability of a system to perform reliably under varying conditions.

The term “versatility” refers to the ability of a system to be adapted for multiple applications.

The term “clinical translation” refers to the process of moving a laboratory discovery into clinical application.

The term “regulatory compliance” refers to adherence to guidelines established by governmental or institutional bodies for the conduct of research and development.

The term “good laboratory practice” or “GLP” refers to a quality system concerned with the organizational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived, and reported.

The term “good manufacturing practice” or “GMP” refers to the regulations and guidelines that ensure products are consistently produced and controlled according to quality standards.

The term “preclinical study” refers to research conducted in laboratory models before testing in humans.

The term “clinical trial” refers to a research study performed in human participants to evaluate a medical, surgical, or behavioral intervention.

The term “informed consent” refers to the voluntary agreement of a participant to take part in a research study after being fully informed of its purpose, procedures, risks, and benefits.

The term “institutional review board” or “IRB” refers to an independent committee that reviews and approves research involving human subjects.

The term “biosafety level” refers to the containment precautions required to handle biological agents safely.

The term “ethical approval” refers to formal authorization granted by an ethics committee for the conduct of research involving human or animal subjects.

The term “animal model” refers to a non-human organism used to study biological processes or disease.

The term “murine model” refers to a mouse model used in biomedical research.

The term “humanized mouse” refers to a mouse engrafted with human cells or tissues.

The term “organoid” refers to a three-dimensional tissue culture derived from stem cells that recapitulates aspects of organ structure and function.

The term “primary cell” refers to a cell isolated directly from tissue and not immortalized.

The term “immortalized cell line” refers to a cell line that has acquired the ability to divide indefinitely in culture.

The term “stem cell” refers to an undifferentiated cell capable of self-renewal and differentiation into multiple cell types.

The term “pluripotent stem cell” refers to a stem cell capable of differentiating into any cell type of the body.

The term “multipotent stem cell” refers to a stem cell capable of differentiating into a limited number of cell types.

The term “hematopoietic stem cell” or “HSC” refers to a stem cell that gives rise to all blood cell types.

The term “neural stem cell” refers to a stem cell that gives rise to neurons and glial cells.

The term “mesenchymal stem cell” refers to a stem cell that gives rise to bone, cartilage, and fat cells.

The term “induced pluripotent stem cell” or “iPSC” refers to a somatic cell reprogrammed to a pluripotent state.

The term “gene correction” refers to the precise repair of a disease-causing mutation to restore normal gene function.

The term “gene knockout” refers to the disruption of a gene to eliminate its function.

The term “gene insertion” refers to the addition of a new gene or sequence into the genome.

The term “gene tagging” refers to the fusion of a reporter or affinity tag to an endogenous gene to enable its detection or purification.

The term “multiplexed delivery” refers to the simultaneous delivery of multiple genetic components.

The term “single-vector system” refers to a system in which all components are encoded on a single nucleic acid molecule.

The term “dual-vector system” refers to a system in which components are encoded on two separate nucleic acid molecules.

The term “co-transfection” refers to the simultaneous transfection of two or more nucleic acid constructs.

The term “co-transduction” refers to the simultaneous transduction of two or more viral vectors.

The term “sequential delivery” refers to the delivery of components at different time points.

The term “temporal control” refers to the ability to regulate the timing of gene expression or activity.

The term “spatial control” refers to the ability to restrict gene expression or activity to specific tissues or cell types.

The term “tissue-specific promoter” refers to a promoter that drives gene expression only in certain tissues.

The term “cell-type-specific enhancer” refers to an enhancer element that activates transcription only in specific cell types.

The term “inducible promoter” refers to a promoter whose activity can be turned on or off by an external stimulus.

The term “repressible promoter” refers to a promoter whose activity can be turned off by an external stimulus.

The term “autonomous expression” refers to the ability of a gene to be expressed without requiring external factors.

The term “regulated expression” refers to expression that is controlled by external or internal signals.

The term “minimal promoter” refers to a promoter containing only the essential elements required for transcription initiation.

The term “synthetic promoter” refers to a promoter engineered from multiple regulatory elements.

The term “bidirectional promoter” refers to a promoter that drives transcription in both directions.

The term “polymerase II promoter” refers to a promoter that directs transcription by RNA polymerase II.

The term “polymerase III promoter” refers to a promoter that directs transcription by RNA polymerase III, such as U6 or H1.

The term “intronic sequence” refers to a non-coding sequence within a gene that is removed during RNA splicing.

The term “exonic sequence” refers to a coding sequence within a gene that is retained in the mature mRNA.

The term “untranslated region” or “UTR” refers to the portions of an mRNA that are not translated into protein.

The term “5′ UTR” refers to the region upstream of the start codon.

The term “3′ UTR” refers to the region downstream of the stop codon.

The term “Kozak sequence” refers to a nucleotide sequence surrounding the start codon that enhances translation initiation.

The term “stop codon” refers to a triplet nucleotide sequence (UAA, UAG, UGA) that terminates translation.

The term “start codon” refers to the nucleotide sequence (AUG) that initiates translation.

The term “reading frame” refers to the way in which a sequence of nucleotides is divided into codons for translation.

The term “frameshift mutation” refers to an insertion or deletion of nucleotides that alters the reading frame.

The term “in-frame insertion” refers to an insertion of nucleotides that maintains the original reading frame.

The term “nucleotide” refers to the basic building block of DNA or RNA.

The term “base pair” refers to a pair of complementary nucleotides held together by hydrogen bonds.

The term “oligonucleotide” refers to a short sequence of nucleotides.

The term “primer” refers to a short oligonucleotide used to initiate DNA synthesis.

The term “probe” refers to a labeled nucleic acid sequence used to detect a complementary sequence.

The term “restriction enzyme” refers to an enzyme that cuts DNA at specific recognition sites.

The term “ligase” refers to an enzyme that joins DNA fragments together.

The term “polymerase” refers to an enzyme that synthesizes nucleic acids.

The term “reverse transcriptase” refers to an enzyme that synthesizes DNA from an RNA template.

The term “nuclease” refers to an enzyme that cleaves nucleic acids.

The term “endonuclease” refers to a nuclease that cleaves internal phosphodiester bonds.

The term “exonuclease” refers to a nuclease that cleaves terminal phosphodiester bonds.

The term “phosphodiester bond” refers to the covalent linkage between nucleotides in DNA or RNA.

The term “hydrogen bond” refers to a weak electrostatic attraction between a hydrogen atom and an electronegative atom.

The term “van der Waals forces” refer to weak intermolecular attractions between atoms or molecules.

The term “electrostatic interaction” refers to the attraction or repulsion between charged particles.

The term “hydrophobic interaction” refers to the tendency of nonpolar molecules to aggregate in aqueous environments.

The term “hydrophilic interaction” refers to the tendency of polar molecules to interact with water.

The term “molecular weight” refers to the mass of a molecule.

The term “molarity” refers to the concentration of a solution in moles per liter.

The term “micromolar” refers to a concentration of one millionth of a mole per liter.

The term “nanomolar” refers to a concentration of one billionth of a mole per liter.

The term “picomolar” refers to a concentration of one trillionth of a mole per liter.

The term “microgram” refers to one millionth of a gram.

The term “nanogram” refers to one billionth of a gram.

The term “picogram” refers to one trillionth of a gram.

The term “microliter” refers to one millionth of a liter.

The term “nanoliter” refers to one billionth of a liter.

The term “picoliter” refers to one trillionth of a liter.

The term “centrifugal force” refers to the force exerted on a substance in a centrifuge, measured in multiples of gravity (g).

The term “temperature gradient” refers to a difference in temperature between two regions.

The term “incubation time” refers to the duration for which a reaction is allowed to proceed.

The term “reaction volume” refers to the total volume of a reaction mixture.

The term “buffer” refers to a solution that resists changes in pH.

The term “chelating agent” refers to a compound that binds metal ions.

The term “reducing agent” refers to a compound that donates electrons.

The term “oxidizing agent” refers to a compound that accepts electrons.

The term “denaturing agent” refers to a compound that disrupts protein structure.

The term “stabilizing agent” refers to a compound that preserves molecular integrity.

The term “cryoprotectant” refers to a compound that protects cells from freezing damage.

The term “antimicrobial agent” refers to a compound that inhibits microbial growth.

The term “antifungal agent” refers to a compound that inhibits fungal growth.

The term “antiviral agent” refers to a compound that inhibits viral replication.

The term “cytotoxic agent” refers to a compound that kills cells.

The term “cytostatic agent” refers to a compound that inhibits cell proliferation.

The term “apoptosis” refers to programmed cell death.

The term “necrosis” refers to accidental cell death due to injury.

The term “senescence” refers to irreversible cell cycle arrest.

The term “autophagy” refers to the degradation of cellular components by lysosomes.

The term “mitosis” refers to nuclear division.

The term “meiosis” refers to the reductional cell division that produces gametes.

The term “interphase” refers to the phase of the cell cycle between mitoses.

The term “G1 phase” refers to the first gap phase of the cell cycle, during which the cell grows.

The term “S phase” refers to the synthesis phase of the cell cycle, during which DNA is replicated.

The term “G2 phase” refers to the second gap phase of the cell cycle, during which the cell prepares for mitosis.

The term “M phase” refers to the mitotic phase of the cell cycle, during which the nucleus divides.

The term “cytokinesis” refers to the division of the cytoplasm following nuclear division.

The term “cell cycle arrest” refers to the halting of cell cycle progression.

The term “checkpoint” refers to a control mechanism that ensures the fidelity of cell cycle progression.

The term “DNA damage checkpoint” refers to a checkpoint that halts the cell cycle in response to DNA damage.

The term “G1/S checkpoint” refers to a checkpoint that prevents entry into S phase if DNA damage is detected.

The term “G2/M checkpoint” refers to a checkpoint that prevents entry into mitosis if DNA damage is detected.

The term “spindle assembly checkpoint” refers to a checkpoint that ensures proper chromosome attachment to the mitotic spindle.

The term “chromosome segregation” refers to the distribution of chromosomes to daughter cells during mitosis.

The term “aneuploidy” refers to an abnormal number of chromosomes.

The term “polyploidy” refers to the presence of more than two complete sets of chromosomes.

The term “genomic instability” refers to an increased tendency for alterations in the genome.

The term “mutagenesis” refers to the process by which the genetic information of an organism is changed.

The term “recombination” refers to the exchange of genetic material between DNA molecules.

The term “homologous recombination” refers to recombination between sequences with high similarity.

The term “non-homologous recombination” refers to recombination between sequences with low or no similarity.

The term “transposition” refers to the movement of a DNA segment from one location to another.

The term “insertion” refers to the addition of nucleotides into a DNA sequence.

The term “deletion” refers to the removal of nucleotides from a DNA sequence.

The term “substitution” refers to the replacement of one nucleotide with another.

The term “inversion” refers to the reversal of a segment of DNA.

The term “duplication” refers to the copying of a segment of DNA.

The term “translocation” refers to the movement of a segment of DNA from one chromosome to another.

The term “amplification” refers to the increase in copy number of a DNA segment.

The term “loss of heterozygosity” refers to the loss of one allele at a heterozygous locus.

The term “epigenetic silencing” refers to the repression of gene expression through chromatin modifications.

The term “transcriptional noise” refers to random fluctuations in gene expression.

The term “gene expression profile” refers to the set of genes expressed in a cell or tissue.

The term “transcriptome” refers to the complete set of RNA transcripts in a cell or tissue.

The term “proteome” refers to the complete set of proteins in a cell or tissue.

The term “metabolome” refers to the complete set of metabolites in a cell or tissue.

The term “phenome” refers to the complete set of observable characteristics of an organism.

The term “genotype” refers to the genetic constitution of an organism.

The term “phenotype” refers to the observable characteristics of an organism.

The term “wild-type” refers to the typical or naturally occurring form of a gene or organism.

The term “mutant” refers to an organism or gene that differs from the wild-type.

The term “knockout” refers to a mutant in which a gene has been inactivated.

The term “knock-in” refers to a mutant in which a gene or sequence has been inserted.

The term “transgenic” refers to an organism containing foreign DNA.

The term “gene-edited” refers to an organism whose genome has been modified by genome editing technologies.

The term “precision genome editing” refers to genome editing with nucleotide-level accuracy.

The term “targeted integration” refers to the insertion of DNA at a specific genomic locus.

The term “random integration” refers to the insertion of DNA at unpredictable genomic locations.

The term “site-specific integration” refers to integration at a predetermined genomic site.

The term “safe harbor site” refers to a genomic locus that permits safe and stable transgene expression.

The term “genomic safe harbor” refers to a locus that minimizes the risk of insertional mutagenesis.

The term “chromosomal locus” refers to the specific physical location of a gene or DNA sequence on a chromosome.

The term “allele” refers to one of two or more alternative forms of a gene.

The term “homozygous” refers to having two identical alleles at a locus.

The term “heterozygous” refers to having two different alleles at a locus.

The term “dominant” refers to an allele that expresses its phenotype in the heterozygous state.

The term “recessive” refers to an allele that expresses its phenotype only in the homozygous state.

The term “penetrance” refers to the proportion of individuals with a genotype who exhibit the associated phenotype.

The term “expressivity” refers to the degree to which a genotype is expressed in the phenotype.

The term “mosaic” refers to an organism composed of cells with different genotypes.

The term “chimeric” refers to an organism composed of cells from different zygotes.

The term “germline” refers to the lineage of cells that give rise to gametes.

The term “somatic” refers to all cells of the body except the germline.

The term “inherited” refers to a trait passed from parent to offspring.

The term “acquired” refers to a trait developed during the lifetime of an organism.

The term “constitutional” refers to a trait present in all cells of the body.

The term “somatic mutation” refers to a mutation occurring in non-germline cells.

The term “germline mutation” refers to a mutation occurring in germ cells.

The term “de novo mutation” refers to a mutation not inherited from either parent.

The term “heritable” refers to a trait capable of being passed to offspring.

The term “non-heritable” refers to a trait not capable of being passed to offspring.

The term “clinical application” refers to the use of a technology in the treatment of human disease.

The term “therapeutic intervention” refers to a procedure or treatment designed to improve health.

The term “preventive medicine” refers to measures taken to prevent disease.

The term “regenerative medicine” refers to therapies that restore or replace damaged tissues or organs.

The term “personalized medicine” refers to medical treatment tailored to the individual characteristics of a patient.

The term “precision medicine” refers to medical treatment based on genetic, environmental, and lifestyle factors.

The term “gene therapy” refers to the treatment of disease by introducing, removing, or altering genetic material within a patient’s cells.

The term “ex vivo gene therapy” refers to gene therapy performed on cells outside the body before reinfusion.

The term “in vivo gene therapy” refers to gene therapy performed directly within the body.

The term “viral vector” refers to a virus engineered to deliver genetic material.

The term “non-viral vector” refers to a non-viral method of delivering genetic material, such as liposomes or nanoparticles.

The term “delivery efficiency” refers to the proportion of cells that receive the intended genetic material.

The term “transfection efficiency” refers to the proportion of cells that take up exogenous nucleic acids by transfection.

The term “transduction efficiency” refers to the proportion of cells that take up exogenous nucleic acids by transduction.

The term “expression level” refers to the amount of a gene product produced in a cell.

The term “protein expression” refers to the production of a protein from its gene.

The term “mRNA expression” refers to the production of mRNA from its gene.

The term “gene silencing” refers to the reduction of gene expression.

The term “gene activation” refers to the increase of gene expression.

The term “transcriptional regulation” refers to the control of gene transcription.

The term “post-transcriptional regulation” refers to the control of gene expression after transcription.

The term “translational regulation” refers to the control of protein synthesis.

The term “post-translational regulation” refers to the control of protein function after synthesis.

The term “protein degradation” refers to the breakdown of proteins by cellular machinery.

The term “ubiquitination” refers to the addition of ubiquitin to a protein, often targeting it for degradation.

The term “proteasome” refers to a cellular complex that degrades ubiquitinated proteins.

The term “lysosome” refers to a cellular organelle that degrades macromolecules.

The term “autophagy” refers to the degradation of cellular components by lysosomes.

The term “endocytosis” refers to the uptake of extracellular material into the cell.

The term “exocytosis” refers to the release of intracellular material from the cell.

The term “membrane trafficking” refers to the movement of vesicles within the cell.

The term “organelle” refers to a specialized subunit within a cell with a specific function.

The term “nucleus” refers to the membrane-bound organelle containing the genome.

The term “cytoplasm” refers to the material within the cell membrane but outside the nucleus.

The term “mitochondrion” refers to the organelle responsible for energy production.

The term “endoplasmic reticulum” refers to the network of membranes involved in protein and lipid synthesis.

The term “Golgi apparatus” refers to the organelle responsible for modifying, sorting, and packaging proteins.

The term “lysosome” refers to the organelle responsible for degradation.

The term “peroxisome” refers to the organelle responsible for breaking down fatty acids and detoxifying alcohol.

The term “cytoskeleton” refers to the network of filaments that provides structural support.

The term “microtubule” refers to a cytoskeletal filament involved in intracellular transport.

The term “actin filament” refers to a cytoskeletal filament involved in cell motility.

The term “intermediate filament” refers to a cytoskeletal filament providing mechanical strength.

The term “cell membrane” refers to the lipid bilayer enclosing the cell.

The term “plasma membrane” refers to the membrane surrounding the cytoplasm.

The term “nuclear membrane” refers to the double membrane surrounding the nucleus.

The term “nuclear pore” refers to a channel in the nuclear membrane that allows transport between nucleus and cytoplasm.

The term “chromatin” refers to the complex of DNA and proteins in the nucleus.

The term “nucleosome” refers to the basic unit of chromatin, consisting of DNA wrapped around histone proteins.

The term “histone” refers to a family of proteins that package and order DNA into structural units.

The term “acetylation” refers to the addition of an acetyl group to a molecule.

The term “methylation” refers to the addition of a methyl group to a molecule.

The term “phosphorylation” refers to the addition of a phosphate group to a molecule.

The term “ubiquitination” refers to the addition of ubiquitin to a protein.

The term “sumoylation” refers to the addition of SUMO to a protein.

The term “palmitoylation” refers to the addition of a palmitoyl group to a protein.

The term “glycosylation” refers to the addition of a sugar group to a molecule.

The term “proteolytic cleavage” refers to the breakdown of a protein by proteases.

The term “post-translational modification” refers to the chemical modification of a protein after translation.

The term “molecular weight marker” refers to a set of proteins of known size used to estimate the size of unknown proteins.

The term “loading control” refers to a protein used to normalize for equal protein loading in assays.

The term “housekeeping gene” refers to a gene that is constitutively expressed and used as a reference in gene expression studies.

The term “reference gene” refers to a gene used to normalize gene expression data.

The term “internal control” refers to a control used within an experiment to ensure validity.

The term “positive control” refers to a sample expected to produce a positive result.

The term “negative control” refers to a sample expected to produce a negative result.

The term “blank control” refers to a sample containing no sample material.

The term “mock transfection” refers to a transfection without nucleic acid.

The term “mock transduction” refers to a transduction without viral vector.

The term “vehicle control” refers to a control containing the solvent used to deliver a compound.

The term “untreated control” refers to a control not subjected to any experimental manipulation.

The term “sham treatment” refers to a control procedure that mimics the experimental treatment without delivering the active agent.

The term “dose-response” refers to the relationship between the dose of a substance and its effect.

The term “time-course” refers to the measurement of a variable over time.

The term “replicate” refers to an independent repetition of an experiment.

The term “biological replicate” refers to an experiment performed using independently derived biological samples.

The term “technical replicate” refers to an experiment performed using the same biological sample.

The term “mean” refers to the average value of a set of numbers.

The term “median” refers to the middle value of a set of numbers.

The term “mode” refers to the most frequently occurring value in a set of numbers.

The term “standard deviation” refers to a measure of the dispersion of a set of values.

The term “variance” refers to the square of the standard deviation.

The term “confidence interval” refers to a range of values likely to include the true population parameter.

The term “p-value” refers to the probability that the observed result occurred by chance.

The term “significance level” refers to the threshold for determining statistical significance.

The term “alpha level” refers to the probability of rejecting the null hypothesis when it is true.

The term “beta level” refers to the probability of failing to reject the null hypothesis when it is false.

The term “power” refers to the probability of correctly rejecting a false null hypothesis.

The term “effect size” refers to the magnitude of the difference between groups.

The term “coefficient of variation” refers to the ratio of the standard deviation to the mean.

The term “correlation coefficient” refers to a measure of the linear relationship between two variables.

The term “linear regression” refers to a statistical method for modeling the relationship between variables.

The term “ANOVA” refers to analysis of variance, a statistical test for comparing means among multiple groups.

The term “Tukey’s test” refers to a post-hoc test for comparing all pairs of means after ANOVA.

The term “Bonferroni correction” refers to a method for adjusting p-values to account for multiple comparisons.

The term “false discovery rate” refers to the expected proportion of false positives among significant results.

The term “multiple testing” refers to the problem of increased false positives when performing multiple statistical tests.

The term “data normalization” refers to the process of scaling data to a common range.

The term “log transformation” refers to the application of a logarithmic function to data.

The term “z-score” refers to the number of standard deviations a value is from the mean.

The term “fold change” refers to the ratio of two values.

The term “threshold” refers to a value used to classify data.

The term “cut-off” refers to a value used to define inclusion or exclusion criteria.

The term “filter” refers to a method of selecting data based on criteria.

The term “gate” refers to a region in a flow cytometry plot used to select a subset of cells.

The term “population” refers to a group of cells sharing a common characteristic.

The term “subpopulation” refers to a subset of a larger population.

The term “cluster” refers to a group of similar data points.

The term “dimensionality reduction” refers to the process of reducing the number of random variables under consideration.

The term “principal component analysis” refers to a statistical method for reducing dimensionality.

The term “t-distributed stochastic neighbor embedding” refers to a method for visualizing high-dimensional data.

The term “heat map” refers to a graphical representation of data where values are represented as colors.

The term “scatter plot” refers to a graph of plotted points representing two variables.

The term “bar graph” refers to a graph using rectangular bars to represent values.

The term “line graph” refers to a graph using lines to represent trends.

The term “box plot” refers to a graph showing the distribution of data using quartiles.

The term “violin plot” refers to a graph combining a box plot with a kernel density plot.

The term “histogram” refers to a graph showing the distribution of a single variable.

The term “pie chart” refers to a circular chart divided into sectors to illustrate proportions.

The term “flow cytometry” refers to a technique for analyzing and sorting cells based on their physical and chemical properties.

The term “fluorescence” refers to the emission of light by a substance that has absorbed light.

The term “excitation” refers to the absorption of energy by a molecule.

The term “emission” refers to the release of energy by a molecule.

The term “wavelength” refers to the distance between successive crests of a wave.

The term “nanometer” refers to one billionth of a meter.

The term “micrometer” refers to one millionth of a meter.

The term “millimeter” refers to one thousandth of a meter.

The term “centimeter” refers to one hundredth of a meter.

The term “meter” refers to the base unit of length.

The term “second” refers to the base unit of time.

The term “minute” refers to sixty seconds.

The term “hour” refers to sixty minutes.

The term “day” refers to twenty-four hours.

The term “week” refers to seven days.

The term “month” refers to approximately thirty days.

The term “year” refers to three hundred sixty-five days.

The term “temperature” refers to the degree of hotness or coldness of a body or environment.

The term “degrees Celsius” refers to a unit of temperature on the Celsius scale.

The term “degrees Fahrenheit” refers to a unit of temperature on the Fahrenheit scale.

The term “Kelvin” refers to the base unit of thermodynamic temperature.

The term “humidity” refers to the amount of water vapor in the air.

The term “atmosphere” refers to the mixture of gases surrounding the Earth.

The term “carbon dioxide” refers to a colorless gas composed of carbon and oxygen.

The term “oxygen” refers to a colorless, odorless gas essential for respiration.

The term “nitrogen” refers to a colorless, odorless gas making up most of the Earth’s atmosphere.

The term “argon” refers to a noble gas used in inert atmospheres.

The term “pressure” refers to the force applied perpendicular to the surface of an object.

The term “atmospheric pressure” refers to the pressure exerted by the weight of the atmosphere.

The term “vacuum” refers to a space devoid of matter.

The term “centrifugation” refers to the use of centrifugal force to separate components of a mixture.

The term “g-force” refers to the force of gravity, used to express centrifugal force.

The term “rotor” refers to the rotating part of a centrifuge.

The term “tube” refers to a container used to hold samples during centrifugation.

The term “pellet” refers to the solid material collected at the bottom of a centrifuge tube.

The term “supernatant” refers to the liquid remaining after centrifugation.

The term “resuspension” refers to the process of dissolving a pellet in a liquid medium.

The term “lysis” refers to the breakdown of a cell membrane.

The term “homogenization” refers to the process of making a mixture uniform.

The term “filtration” refers to the process of separating solids from liquids.

The term “centrifugal force” refers to the apparent force that draws a rotating body away from the center of rotation.

The term “viscosity” refers to the resistance of a fluid to flow.

The term “density” refers to the mass per unit volume.

The term “concentration” refers to the amount of a substance in a given volume.

The term “dilution” refers to the reduction in concentration of a solute in solution.

The term “stock solution” refers to a concentrated solution used to prepare working solutions.

The term “working solution” refers to a diluted solution used in experiments.

The term “serial dilution” refers to a series of stepwise dilutions.

The term “dilution factor” refers to the ratio of the final volume to the initial volume.

The term “molarity” refers to the number of moles of solute per liter of solution.

The term “molality” refers to the number of moles of solute per kilogram of solvent.

The term “normality” refers to the number of gram equivalents per liter of solution.

The term “percent solution” refers to the concentration of a solute expressed as a percentage.

The term “weight/volume percent” refers to the mass of solute per volume of solution.

The term “volume/volume percent” refers to the volume of solute per volume of solution.

The term “weight/weight percent” refers to the mass of solute per mass of solution.

The term “parts per million” refers to one part per million parts of solution.

The term “parts per billion” refers to one part per billion parts of solution.

The term “parts per trillion” refers to one part per trillion parts of solution.

The term “equivalent” refers to the amount of a substance that reacts with or supplies one mole of hydrogen ions.

The term “mole” refers to the amount of substance containing as many elementary entities as there are atoms in 12 grams of carbon-12.

The term “Avogadro’s number” refers to the number of particles in one mole, approximately 6.022 × 10^23.

The term “atomic mass” refers to the mass of an atom.

The term “molecular mass” refers to the mass of a molecule.

The term “formula weight” refers to the sum of the atomic weights of all atoms in a chemical formula.

The term “empirical formula” refers to the simplest whole-number ratio of atoms in a compound.

The term “molecular formula” refers to the actual number of atoms of each element in a molecule.

The term “structural formula” refers to a representation of the molecular structure.

The term “isomer” refers to a compound with the same molecular formula but different structure.

The term “enantiomer” refers to a stereoisomer that is a mirror image of another.

The term “diastereomer” refers to a stereoisomer that is not a mirror image.

The term “chiral” refers to a molecule that is not superimposable on its mirror image.

The term “achiral” refers to a molecule that is superimposable on its mirror image.

The term “stereocenter” refers to an atom with four different substituents.

The term “racemic mixture” refers to a 50:50 mixture of two enantiomers.

The term “optical rotation” refers to the ability of a chiral compound to rotate plane-polarized light.

The term “polarimeter” refers to an instrument used to measure optical rotation.

The term “solubility” refers to the ability of a substance to dissolve in a solvent.

The term “partition coefficient” refers to the ratio of concentrations of a compound in two immiscible solvents.

The term “logP” refers to the logarithm of the partition coefficient.

The term “pKa” refers to the acid dissociation constant.

The term “pH” refers to the measure of acidity or alkalinity of a solution.

The term “buffer capacity” refers to the ability of a buffer to resist pH change.

The term “titration” refers to the determination of the concentration of a substance by reaction with a standard solution.

The term “endpoint” refers to the point at which a reaction is complete.

The term “equivalence point” refers to the point at which stoichiometrically equivalent amounts of reactants have been mixed.

The term “indicator” refers to a substance that changes color at a specific pH.

The term “electrophoresis” refers to the movement of charged particles in an electric field.

The term “agarose gel” refers to a gel made from agarose used for DNA separation.

The term “polyacrylamide gel” refers to a gel made from acrylamide used for protein or small DNA separation.

The term “denaturing gel” refers to a gel that separates molecules based on size under denaturing conditions.

The term “native gel” refers to a gel that separates molecules based on size and charge under non-denaturing conditions.

The term “Western blot” refers to a technique for detecting specific proteins in a sample.

The term “Southern blot” refers to a technique for detecting specific DNA sequences.

The term “Northern blot” refers to a technique for detecting specific RNA sequences.

The term “Eastern blot” refers to a technique for detecting post-translational modifications.

The term “immunoblot” refers to a blotting technique using antibodies.

The term “antibody” refers to a protein produced by the immune system that binds to a specific antigen.

The term “monoclonal antibody” refers to an antibody produced by a single clone of cells.

The term “polyclonal antibody” refers to an antibody produced by multiple clones of cells.

The term “antigen” refers to a substance that induces an immune response.

The term “epitope” refers to the part of an antigen that is recognized by an antibody.

The term “affinity” refers to the strength of binding between two molecules.

The term “avidity” refers to the overall strength of binding between multiple interactions.

The term “specificity” refers to the ability to distinguish between similar molecules.

The term “cross-reactivity” refers to the binding of an antibody to a non-target antigen.

The term “blocking agent” refers to a substance used to prevent non-specific binding.

The term “washing buffer” refers to a buffer used to remove unbound material.

The term “detection reagent” refers to a substance used to visualize a target.

The term “enzyme conjugate” refers to an antibody linked to an enzyme.

The term “fluorophore” refers to a molecule that emits fluorescence.

The term “fluorescence microscopy” refers to imaging using fluorescence.

The term “confocal microscopy” refers to a technique for optical sectioning using a pinhole.

The term “live-cell imaging” refers to imaging of living cells over time.

The term “time-lapse microscopy” refers to recording images at intervals to show change over time.

The term “fluorescence resonance energy transfer” refers to a mechanism of energy transfer between two fluorophores.

The term “FRET” refers to fluorescence resonance energy transfer.

The term “quantum dot” refers to a semiconductor nanocrystal that emits light.

The term “bioluminescence” refers to light produced by a living organism.

The term “luciferase” refers to an enzyme that catalyzes bioluminescence.

The term “ATP” refers to adenosine triphosphate, the primary energy currency of the cell.

The term “NADH” refers to nicotinamide adenine dinucleotide, a coenzyme involved in redox reactions.

The term “NADPH” refers to nicotinamide adenine dinucleotide phosphate, a coenzyme involved in anabolic reactions.

The term “FADH2” refers to flavin adenine dinucleotide, a coenzyme involved in redox reactions.

The term “coenzyme” refers to a non-protein compound required for enzyme activity.

The term “substrate” refers to a substance upon which an enzyme acts.

The term “product” refers to a substance formed by a chemical reaction.

The term “catalyst” refers to a substance that increases the rate of a reaction without being consumed.

The term “inhibitor” refers to a substance that decreases the rate of a reaction.

The term “activator” refers to a substance that increases the rate of a reaction.

The term “allosteric” refers to regulation at a site other than the active site.

The term “competitive inhibition” refers to inhibition by a molecule that competes with the substrate.

The term “non-competitive inhibition” refers to inhibition by a molecule that binds elsewhere and changes enzyme conformation.

The term “uncompetitive inhibition” refers to inhibition that occurs only after substrate binding.

The term “irreversible inhibition” refers to inhibition that permanently inactivates the enzyme.

The term “reversible inhibition” refers to inhibition that can be reversed.

The term “feedback inhibition” refers to regulation by the end product of a pathway.

The term “feedforward activation” refers to activation by a precursor of a pathway.

The term “signal transduction” refers to the process by which a chemical or physical signal is transmitted through a cell.

The term “receptor” refers to a protein that binds a signaling molecule.

The term “ligand” refers to a molecule that binds to a receptor.

The term “second messenger” refers to an intracellular signaling molecule.

The term “kinase” refers to an enzyme that transfers phosphate groups.

The term “phosphatase” refers to an enzyme that removes phosphate groups.

The term “G protein” refers to a guanine nucleotide-binding protein.

The term “GTP” refers to guanosine triphosphate.

The term “GDP” refers to guanosine diphosphate.

The term “adenylate cyclase” refers to an enzyme that converts ATP to cyclic AMP.

The term “cAMP” refers to cyclic adenosine monophosphate.

The term “protein kinase A” refers to a kinase activated by cAMP.

The term “phospholipase C” refers to an enzyme that cleaves phospholipids.

The term “IP3” refers to inositol trisphosphate.

The term “DAG” refers to diacylglycerol.

The term “calcium” refers to a divalent cation involved in signaling.

The term “calmodulin” refers to a calcium-binding protein.

The term “transcription factor” refers to a protein that binds DNA and regulates transcription.

The term “activator” refers to a transcription factor that increases transcription.

The term “repressor” refers to a transcription factor that decreases transcription.

The term “enhancer” refers to a DNA sequence that increases transcription.

The term “silencer” refers to a DNA sequence that decreases transcription.

The term “promoter” refers to a DNA sequence that initiates transcription.

The term “terminator” refers to a DNA sequence that ends transcription.

The term “polyadenylation” refers to the addition of a poly-A tail to mRNA.

The term “splicing” refers to the removal of introns from pre-mRNA.

The term “exon” refers to a coding region of a gene.

The term “intron” refers to a non-coding region of a gene.

The term “splice site” refers to the boundary between an exon and an intron.

The term “5′ splice site” refers to the donor site at the beginning of an intron.

The term “3′ splice site” refers to the acceptor site at the end of an intron.

The term “branch point” refers to the nucleotide where the intron is cleaved during splicing.

The term “cap” refers to the modified guanine nucleotide at the 5′ end of mRNA.

The term “poly-A tail” refers to a string of adenine nucleotides at the 3′ end of mRNA.

The term “ribosome” refers to the cellular machinery that translates mRNA into protein.

The term “mRNA” refers to messenger RNA.

The term “tRNA” refers to transfer RNA.

The term “rRNA” refers to ribosomal RNA.

The term “snRNA” refers to small nuclear RNA.

The term “snoRNA” refers to small nucleolar RNA.

The term “miRNA” refers to microRNA.

The term “siRNA” refers to small interfering RNA.

The term “piRNA” refers to Piwi-interacting RNA.

The term “lncRNA” refers to long non-coding RNA.

The term “circular RNA” refers to a covalently closed RNA molecule.

The term “ribonucleoprotein” refers to a complex of RNA and protein.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The term “Venus” refers to a yellow fluorescent protein.

The term “T2A” refers to a self-cleaving peptide.

The term “SA” refers to a splice acceptor.

The term “PA” refers to a polyadenylation signal.

The term “homology arm” refers to a sequence homologous to the target site.

The term “left homology arm” refers to the homologous sequence upstream of the break.

The term “right homology arm” refers to the homologous sequence downstream of the break.

The term “AAVS1” refers to a safe harbor locus on chromosome 19.

The term “ACTB” refers to the beta-actin gene.

The term “HEK293” refers to human embryonic kidney cells.

The term “HEK293T” refers to HEK293 cells expressing SV40 large T antigen.

The term “HeLa” refers to a human cervical cancer cell line.

The term “CRISPR” refers to clustered regularly interspaced short palindromic repeats.

The term “Cas9” refers to CRISPR-associated protein 9.

The term “sgRNA” refers to single guide RNA.

The term “dgRNA” refers to catalytically inactive guide RNA.

The term “CRISPRa” refers to CRISPR activation.

The term “CRISPRi” refers to CRISPR interference.

The term “MCP” refers to MS2 coat protein.

The term “MPH” refers to MCP-P65-HSF1 fusion protein.

The term “Com” refers to Com protein.

The term “CK” refers to Com-KRAB fusion protein.

The term “TRE3G” refers to tetracycline-responsive element 3G.

The term “rtTA” refers to reverse tetracycline-controlled transactivator.

The term “doxycycline” refers to a tetracycline-class antibiotic used as an inducer.

The term “lentivirus” refers to a retrovirus used for gene delivery.

The term “AAV” refers to adeno-associated virus.

The term “plasmid” refers to a circular DNA molecule used for gene expression.

The term “vector” refers to a nucleic acid molecule used to deliver genetic material.

The term “transfection” refers to the introduction of nucleic acids into cells.

The term “transduction” refers to the introduction of nucleic acids into cells using viruses.

The term “electroporation” refers to the use of electric pulses to introduce nucleic acids.

The term “lipofection” refers to the use of lipid nanoparticles to introduce nucleic acids.

The term “microinjection” refers to the direct injection of nucleic acids into cells.

The term “viral packaging” refers to the production of viral particles.

The term “packaging cell line” refers to a cell line used to produce viral particles.

The term “titer” refers to the concentration of infectious viral particles.

The term “transduction unit” refers to a unit of viral transduction efficiency.

The term “genome editing” refers to the deliberate modification of an organism’s genome.

The term “precise editing” refers to editing with nucleotide-level accuracy.

The term “indel” refers to an insertion or deletion of nucleotides.

The term “frame shift” refers to a mutation that alters the reading frame.

The term “in-frame” refers to a mutation that preserves the reading frame.

The term “knock-in” refers to the insertion of a sequence into a genome.

The term “knock-out” refers to the disruption of a gene.

The term “gene correction” refers to the repair of a mutation.

The term “gene insertion” refers to the addition of a gene.

The term “gene tagging” refers to the fusion of a tag to a gene.

The term “reporter gene” refers to a gene whose product is easily detectable.

The term “fluorescent protein” refers to a protein that emits light.

The term “EGFP” refers to enhanced green fluorescent protein.

The term “mCherry” refers to a red fluorescent protein.

The